Why the study?
Does the magnitude of change in thallium activity after reinjection distinguish viable from nonviable myocardium in patients with coronary artery disease?
Population
150 patients with coronary artery disease
Design
Cross-sectional
Authors
Loading...
May distinguish viability in irreversible defects; leaves open outcome impact of reinjection protocols in CAD.
Does the magnitude of change in thallium activity after reinjection distinguish viable from nonviable myocardium in patients with coronary artery disease?
The magnitude of thallium uptake after reinjection can distinguish viable from nonviable myocardium in regions with irreversible defects on standard redistribution images.
Dilsizian et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: